We’ve all heard these metrics — 31 percent of Phase 2 and 30 percent of Phase 3 trials are running longer. And site staff members are over-resourced. Time delays demotivate site performance. There are three pieces to the puzzle to make clinical trials successful, including pharmaceutical/biotechnology companies,…
Having recently returned from this year’s Site Solutions Summit, it seems appropriate to share some reflections. Being on the Global Impact Partners Advisory Board for the Society for Clinical Research Sites (SCRS) provides a unique view into the planning and purpose of the summit. I can say…
Retention is the cornerstone of successful clinical trial completion; therefore, it is essential that subjects comply with study requirements, including visit schedules. Communication is key, and the easier the mode of communication, the better. That’s why text messaging has emerged as a convenient high-tech alternative…
As industry professionals, we spend a lot of time and energy writing, designing and producing materials in support of clinical trials. During this process, shipping materials to their final destination is often an afterthought, with address information provided at the last minute. This is not…
Early in my tenure with DAC Patient Recruitment Services, back when we were D. Anderson & Company, we presented a proposal defense to a pharmaceutical company that was sponsoring a study aimed at a particular ethnic group. The sponsor needed help creating a patient recruitment…